Elekta AB engages in the business of human care, which specializes in the provision of clinical solutions for the treatment of cancers and brain disorders. Its products and solutions include radiotherapy, stereotactic radiosurgery, oncology informatics, brachytheraphy, neurosurgery, and particle therapy. It operates through the following geographical segments: North and South America; Europe. Middle East and Africa; and Asia Pacific. The company was founded by Lars Leksell and Laurent Leksell in 1972 and is headquartered in Stockholm, Sweden.